Becton Dickinson raises dividend for 46th consecutive year
This marks the 46th consecutive year of dividend increases for the medical technology company.
Dividend Aristocrat Becton Dickinson (BDX) will raise its dividend by 2.7 percent to $0.75 per share in Q4 of 2017. The new dividend yield for BDX is 1.3%.
The dividend will be payable on December 29, 2017 to holders of record on December 8, 2017.
"We are very pleased with our strong fiscal 2017 results, which demonstrate our ability to overcome multiple headwinds and deliver on our commitments. We enter fiscal 2018 with continued momentum in our core and look forward to the successful closing of the C.R. Bard acquisition. We believe there are significant opportunities ahead for BD as we continue to deliver innovative healthcare solutions to our customers and their patients around the world," said Vincent A. Forlenza, Chairman and CEO. "This is the forty-sixth consecutive fiscal year in which we have raised our dividend. This increase reflects our confidence in our long-term outlook, as well as our ongoing commitment to create value and return capital to our shareholders."
In 2016 Becton Dickinson raised its dividend for the 45th consecutive year.
Becton, Dickinson is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through its Medical and Life Sciences segments. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.
